Abstract:A targeted drug delivery system utilizing folic acidconjugated curcumin for selective targeting of MCF‐7 breast cancer cells is illustrated. The system exploits the overexpression of folate receptors on MCF‐7 cells, enabling specific recognition and binding of the folic acidmodified drug carrier. Upon receptor‐mediated endocytosis, the encapsulated curcumin is internalized into the cancer cells, where it is released to exert its therapeutic effects. This selective targeting mechanism enhances the drug's bioavailability and therapeutic efficacy while minimizing potential side effects on healthy cells. The folate receptormediated targeting strategy demonstrates enhanced cellular uptake and cytotoxicity specifically in MCF‐7 breast cancer cells, leading to programmed cell death. This study explores the therapeutic potential of curcumin (CUR) in cancer therapy, specifically examining its targeted transport through folate receptors and its interaction with certain proteins in breast cancer cell lines. We employed molecular docking technique to assess the binding affinities of CUR with proteins 1H1Q, 1UOM, 4JDD, 5U2D and MCF10A normal breast epithelial cell line protein 5UGB. Out of these, the CUR–1H1Q complex exhibited the greatest binding affinity. To assess the stability of this complex in a biological setting, we conducted molecular dynamics simulations of the 1H1Q–CUR complex for a duration of 100 ns. The simulations demonstrated an extremely stable Cα‐backbone, exhibiting a consistently low root mean square deviation. The radius of gyration measurements suggested a condensed structure with specific areas of flexibility. The simulation revealed a consistent hydrogen bond between CUR and 1H1Q, indicating a robust and long‐lasting interaction between the two molecules. The results indicate that the cytotoxicity of curcumin on MCF7 cancer cell lines is mainly affected by its interactions with several proteins found in these cancer cells. Among the four proteins tested, 1H1Q has the greatest influence. The high affinity of these proteins for curcumin, which results in the creation of stable complexes, seems to trigger cell death. Curcumin's biocompatibility and toxicological effects were investigated in both normal and cancerous cell lines. The study revealed enhanced biocompatibility and potential toxicity in cancerous cell lines, while demonstrating reduced toxicity in normal cell lines.

IN VIVO EVALUATION OF CURCUMIN REVEALS BIPHASIC ANGIOGENESIS ACTIVITY IN ZEBRAFISH EXPERIMENTAL MODEL

Nanocurcumin Inhibits Angiogenesis via Down-regulating hif1a/VEGF-A Signaling in Zebrafish

Preparation of curcumin-loaded poly(ester amine) nanoparticles for the treatment of anti-angiogenesis.

Investigation on the Metabolism of Curcumin and Baicalein in Zebrafish by Liquid Chromatography-tandem Mass Spectrometry Analysis

Antiangiogenic Effect of Curcumin in Pure Versus in Extract Forms

Observation of zebrafish embryonic and larval development at different doses of curcumin solution: the disparity between safe and toxic

Study on Antiangiogenesis Effects of Curcumin

STUDIES ON BIOAVAILABILITY ENHANCEMENT OF CURCUMIN

Enhancement of the anticancer potential and biosafety of BSA-modified, bacterial membrane-coated curcumin nanoparticles

In Silico Analysis of Curcumin's Targeted Cancer Therapy: Folate Receptor Pathways and Molecular Interaction Insights

Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis

Synthesis, characterization, quantum mechanical calculations and biomedical docking studies on curcumin analogs: 2, 6-(Difurfurylidene) cyclohexanone and 2, 6 - Bis (2,6-Dichloro Benzylidene) Cyclohexanone

Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects

Pharmacological safety of dimethoxy curcumin-human serum albumin conjugate for potential therapeutic purpose

Combination of Curcumin and Zerumbone Improves VEGF-A Inhibition in Colorectal Cancer In Vivo and In Vitro Model

Enzymatic formation of curcumin in vitro and in vivo

Highly Bioavailable Forms of Curcumin and Promising Avenues for Curcumin-Based Research and Application: A Review

Evaluation of Curcumin Capped Copper Nanoparticles as Possible Inhibitors of Human Breast Cancer Cells and Angiogenesis: a Comparative Study with Native Curcumin

Formation of Inclusion Complex of Curcumin and Tetrahydrocurcumin Prevents Angiogenesis by Inhibiting VEGF Activity: An in-Silico Study

Enhancing the Bioavailability and Bioactivity of Curcumin for Disease Prevention and Treatment